# Eledon Pharmaceuticals, Inc.: Form 8-K, filed Jun 12, 2025

- Company: [Eledon Pharmaceuticals, Inc.](/companies/eldn.md) (CIK 1404281)
- Form: 8-K
- Filed: 2025-06-12
- Accepted by EDGAR: Jun 12, 2025, 17:28 ET
- Period: 2025-06-10
- Accession: 0000950170-25-085588
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1404281/000095017025085588/eldn-20250610.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404281/000095017025085588/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404281/000095017025085588/eldn-20250610.htm

Filed Jun 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-085588. Last ingested by Listed: Oct 30, 2026, 11:26 ET. No prices; not investment advice.